ESMO 2026

Copenhagen, Denmark, July 17, 2026 Evaxion A/S announced that it will present three-year clinical efficacy data from its Phase...

SAN FRANCISCO, Calif., July 13, 2026 Universal Brain has achieved a significant regulatory milestone after receiving U.S. Food and...

NANJING, China, July 13, 2026 Leads Biolabs has strengthened its position in global cancer immunotherapy after announcing that six...

MUMBAI, India & NAPLES, Fla., June 17, 2026 Lupin Limited, a leading global pharmaceutical company, has announced the launch...

LOS ANGELES, Calif., June 18, 2026 TORL BioTherapeutics has reported encouraging preliminary Phase 1 clinical data for its investigational...

LYON, France — May 28, 2026 Brenus Pharma announced that the U.S. Food and Drug Administration has accepted the...